Navigation Links
drugstore.com inc. Reports Profitable Fourth Quarter of 2008 and Free Cash Flow of $5.4 Million on Record OTC Sales
Date:2/4/2009

pore, chief executive officer and chairman of the board of drugstore.com, inc. "Importantly, while holiday sales were clearly impacted by the economy, we saw strong sales of our everyday OTC basics, reinforcing our belief that a large portion of our products are not considered discretionary by our customers. Overall, we continued to drive solid OTC and vision growth of 6.0% and 14.5%, respectively, significantly ahead of eCommerce trends. During the course of 2008, we strengthened our operational efficiencies, increased margins, and more than doubled our full year adjusted EBITDA over last year. These improvements allowed us to be more promotional in the fourth quarter, while maintaining a strong operating model."

"Looking ahead, our fourth quarter results give us confidence that we can and will continue to grow our OTC and vision revenues amidst a more challenging economic environment. January started off strong, with continued demand for everyday OTC basics, increased FSA sales, and customers' capitalizing on our loyalty program -- drugstore.com dollars(TM). Importantly, we also have a number of key initiatives -- such as ramping our strategic partnerships with Medco and Rite Aid, adding new prestige beauty brands, and expanding international sales -- that leverage our existing infrastructure and which should help fuel growth in 2009," concluded Ms. Lepore.

Net income for the fourth quarter of 2008 was $289,000, or $0.00 per share, compared to a net loss of $2.3 million, or $0.02 per share, for the fourth quarter of 2007. The fourth quarter 2008 income includes $1.8 million in non-cash stock-based compensation expense, compared to $1.7 million for the fourth quarter 2007. Net loss for the fiscal year of 2008 was $8.3 million or $0.09 per share, compared to a net loss of $11.5 million, or $0.12 per share, for the fiscal year of 2007. The 2008 fiscal
'/>"/>

SOURCE drugstore.com, inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine news :

1. drugstore.com and Revolution Health Group Announce Breakthrough Deal
2. drugstore.com, inc. to Announce Third Quarter 2007 Results During Conference Call on Monday, October 22, 2007 at 5:00 p.m. ET
3. drugstore.com inc. Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007
4. drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007
5. drugstore.com, inc. to Present at the Upcoming Jefferies 4th Annual Internet Conference and the Morgan Stanley Technology Conference
6. drugstore.com, inc. to Announce First Quarter 2008 Results During Conference Call on Monday, May 5, 2008 at 5:00 p.m. ET
7. drugstore.com inc. Reports Results for the First Quarter of 2008
8. drugstore.com, inc. to Present at Upcoming Investor Conferences
9. drugstore.com inc. Reports Solid Revenue Growth and Record Gross Margins in the Third Quarter of 2008
10. drugstore.com Offers Free Shipping to U.S. Troops Serving Overseas and in the United States
11. drugstore.com Announces Strategic Alliance With Medco Health Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... 14, 2014 Top nutritional supplement provider ... its Quality Control and Assurance Department. As the company ... additional, highly-qualified quality assurance (QA) and quality control (QC) ... which IQ Formulations has become known. , ... decades of stellar experience and qualifications to their new ...
(Date:7/14/2014)... SingaporeA*STAR,s Bioprocessing Technology Institute (BTI) has entered into ... pharmaceutical company, Roche, to identify novel drug candidates ... partnership brings together BTI,s capabilities in novel antibody ... (mAbs) therapeutics, opening up the possibility of ... death worldwide. , The collaboration makes use ...
(Date:7/14/2014)... BCC Research ( http://www.bccresearch.com ) reveals ... MARKETS , the global synthetic biology market is ... 2018, with a five-year compound annual growth rate ... fastest growing segment, with anticipated $9.7 billion in ... the pharmaceutical/diagnostics, chemical, energy, and agricultural industries compose ...
(Date:7/14/2014)... Botanica Day Spa announced last month ... held at the day spa in down town Clearwater, ... and other refreshments will be served as clients are ... beauty products and great deals on spa services, ... , Dermaplaning (also known as “facial shaving”) is a ...
(Date:7/14/2014)... -- Along with improving vision, cataract surgery may slow ... types of dementia, a new study suggests. Better ... said. "These preliminary results indicate that improved vision ... dementia and their loved ones, both visual and non-visual," ... and University Hospitals Case Medical Center, in Ohio. ...
Breaking Medicine News(10 mins):Health News:Leading Health Supplement Company IQ Formulations Expands Quality Control and Assurance Department 2Health News:A*STAR partners Roche to develop new cancer therapeutics 2Health News:Global Market for Synthetic Biology to Reach Nearly $11.9 Billion by 2018 — Enabled Products Account for the Fastest Growing Segment with 36.7% CAGR 2Health News:Global Market for Synthetic Biology to Reach Nearly $11.9 Billion by 2018 — Enabled Products Account for the Fastest Growing Segment with 36.7% CAGR 3Health News:Botanica Day Spa to Feature Dermaplaning at Upcoming Open House 2Health News:Botanica Day Spa to Feature Dermaplaning at Upcoming Open House 3Health News:Cataract Surgery a Plus for Someone With Dementia, Study Says 2
... SOUTH SAN FRANCISCO, Calif., May 13 Rigel Pharmaceuticals, Inc. ... Gower, the company,s chairman and chief executive officer, is scheduled ... Securities Research Conference in San Francisco on Wednesday, May 20th ... the subsequent archived recording, log on to www.rigel.com . ...
... Science Olympiad to Emphasize the Importance of Fueling Body ... you find America,s brightest young minds launching rockets, crashing ... are part of the 25th annual Science Olympiad National ... first time, the incredible edible egg, on behalf of ...
... Gastroenterologist Offers Tips for Treatment , ... San Bruno, CA (PRWEB) May ... (AGE) affect Americans each year, according to eMedicine from WebMD. ... a viral, bacterial or parasitic infection. Victims are usually hit by ...
... medical search engine will debut on 16 May 2009 at the ... , ... Budapest, Hungary (PRWEB) May 13, 2009 -- Existing ... information to consumers. WebLib CEO Endre Jofoldi notes that "the goal ...
... ( BOVESPA: AMIL3, Bloomberg: AMIL3 BZ and Reuters: AMIL3.SA ... its results for the first quarter of 2009. ... stood at 3.11 million, 9.7% up on the 1Q08 ... 4Q08.Adjusted Operating Revenues totaled R$ 1,131 million in ...
... Adding B vitamin to grain products cut congenital heart defects ... -- Since the mandatory addition of folic acid to flour, ... than a decade ago, fewer babies have been born with ... of vitamin B, has been shown to reduce neural tube ...
Cached Medicine News:Health News:America's Top Young Scientists to Receive Scholarships for Winning Eggs-Periments 2Health News:America's Top Young Scientists to Receive Scholarships for Winning Eggs-Periments 3Health News:America's Top Young Scientists to Receive Scholarships for Winning Eggs-Periments 4Health News:When Stomach Flu Strikes, Work With, Not Against, Body's Natural Defenses 2Health News:Amilpar - Revenue Increases 13.4% and Medical Loss Ratio Falls in the First Quarter 2009 2Health News:Folic Acid Reduces Infant Heart Defects 2
(Date:7/14/2014)... Valeant Pharmaceuticals International, Inc. (NYSE: ... it has filed a premerger notification under the ... the U.S. Federal Trade Commission (FTC) relating to ... About Valeant Pharmaceuticals International, Inc. ... VRX) is a multinational specialty pharmaceutical company that ...
(Date:7/14/2014)... , July 14, 2014 Synthetic ... technology partnership with global bioengineering leader DNA2.0, ... for quick-to-market products. The integration ... machine learning optimization technologies, such as ProteinGPS™ ... process of engineering proteins in the Pareto ...
(Date:7/14/2014)... 2014  Abbott (NYSE: ABT) announced today that it will ... Mylan for equity ownership of a newly formed entity ... Abbott,s developed markets pharmaceuticals business, and will ... of approximately $5.3 billion based on Mylan,s closing stock ... business generated approximately $2 billion in sales in 2013. ...
Breaking Medicine Technology:Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 2Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 3Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 4Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 5Pareto Biotechnologies Announces Technology Partnership With DNA2.0, Inc. 2Pareto Biotechnologies Announces Technology Partnership With DNA2.0, Inc. 3Abbott to Sell its Developed Markets Branded Generics Pharmaceuticals Business to Mylan 2Abbott to Sell its Developed Markets Branded Generics Pharmaceuticals Business to Mylan 3Abbott to Sell its Developed Markets Branded Generics Pharmaceuticals Business to Mylan 4Abbott to Sell its Developed Markets Branded Generics Pharmaceuticals Business to Mylan 5Abbott to Sell its Developed Markets Branded Generics Pharmaceuticals Business to Mylan 6Abbott to Sell its Developed Markets Branded Generics Pharmaceuticals Business to Mylan 7
... /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ: SVA ), ... it has filed its Annual Report on Form 20-F with ... December 31, 2010 on April 22, 2011.  The Annual Report ... The Company will provide a hard copy of ...
... The following release is being issued by law ... Feldman & Pinto: According to two new ... Medical Journal, Bayer,s birth control pills Yaz and Yasmin, ... triple the risk of serious blood clots (known as ...
Cached Medicine Technology:Sinovac Files Annual Report on Form 20-F 2
Sheath Introducers with guidewires....
... design, utilizing an advanced cobalt-based ... stainless steel stents. This stronger ... for unparalleled flexibility plus optimal ... Stent Systemwith thin struts that ...
... Catheter provides support to enhance the ... adverse conditions. It gives you dependable ... your destination in cardiac interventions. It ... of clinical situations and the most ...
... Xtra, and Maximum ACT introducers represent ... specialty hemostasis introducers in the world. ... hemostasis introducers for use in interventional ... angioplasty, stenting, atherectomy, temporary pacing, endomyocardial ...
Medicine Products: